Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Evens

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
The Lancet. Oncology|December 5, 2009
Curing Hodgkin's lymphoma: quantity and qualityAndrew M Evens, Lynne I Wagner
Cancers|November 9, 2024
Deciphering the Metabolic Basis and Molecular Circuitry of the Warburg Paradox in LymphomaDashnamoorthy Ravi, Athena Kritharis, Andrew M Evens
Annals of Hematology|December 18, 2014
Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorderUrvi Shah, Athena Kritharis, Andrew M Evens
JAMA|November 6, 2008
The challenges of epidemiologic research in non-Hodgkin lymphomaAndrew M Evens, Brian C-H Chiu
Cancer Treatment and Research|February 7, 2015
Current therapeutic strategies and new treatment paradigms for follicular lymphomaAthena Kritharis, Jaya Sharma, Andrew M Evens
British Journal of Haematology|June 16, 2016
How I manage patients with grey zone lymphomaAthena Kritharis, Monika Pilichowska, Andrew M Evens
Hematological Oncology|June 19, 2013
XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomesDeepa Jagadeesh, Catherine Diefenbach, Andrew M Evens
Therapeutic Advances in Hematology|April 8, 2016
The evolving role of response-adapted PET imaging in Hodgkin lymphomaMichael Coyle, Lale Kostakoglu, Andrew M Evens
JCO Oncology Practice|March 7, 2022
Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine ShortagePallawi Torka, Eugene Przespolewski, Andrew M Evens
Nature Clinical Practice. Oncology|August 6, 2008
Treatment of Hodgkin lymphoma: the past, present, and futureAndrew M Evens, Martin Hutchings, Volker Diehl
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|December 5, 2009
Curing Hodgkin's lymphoma: quantity and qualityAndrew M Evens, Lynne I Wagner
Cancers|November 9, 2024
Deciphering the Metabolic Basis and Molecular Circuitry of the Warburg Paradox in LymphomaDashnamoorthy Ravi, Athena Kritharis, Andrew M Evens
Annals of Hematology|December 18, 2014
Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorderUrvi Shah, Athena Kritharis, Andrew M Evens
JAMA|November 6, 2008
The challenges of epidemiologic research in non-Hodgkin lymphomaAndrew M Evens, Brian C-H Chiu
Cancer Treatment and Research|February 7, 2015
Current therapeutic strategies and new treatment paradigms for follicular lymphomaAthena Kritharis, Jaya Sharma, Andrew M Evens
British Journal of Haematology|June 16, 2016
How I manage patients with grey zone lymphomaAthena Kritharis, Monika Pilichowska, Andrew M Evens
Hematological Oncology|June 19, 2013
XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomesDeepa Jagadeesh, Catherine Diefenbach, Andrew M Evens
Therapeutic Advances in Hematology|April 8, 2016
The evolving role of response-adapted PET imaging in Hodgkin lymphomaMichael Coyle, Lale Kostakoglu, Andrew M Evens
JCO Oncology Practice|March 7, 2022
Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine ShortagePallawi Torka, Eugene Przespolewski, Andrew M Evens
Nature Clinical Practice. Oncology|August 6, 2008
Treatment of Hodgkin lymphoma: the past, present, and futureAndrew M Evens, Martin Hutchings, Volker Diehl
Pageof 23